144,532 members

Skip to content. | Skip to navigation

News

Pioneering therapy for young people with blood cancer

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

Pioneering therapy for young people with blood cancer

NICE has recommended a pioneering cancer treatment, CART-cell therapy, for people under the age of 25 with leukaemia.

Young people with relapsed or refractory B-cell acute lymphoblastic leukaemia (ALL) will now have access to tisagenlecleucel, also known as Kymriah made by Novartis, through the Cancer Drugs Fund (CDF).

Tisagenlecleucel will be offered to people under the age of 25 who have not responded to current treatment or who have relapsed after stem cell transplant.